# Gilde Healthcare: portfolio, investments and team

> Gilde Healthcare is a private equity based in Netherlands. 56 investments on record, 3 in the last 12 months, latest Jun 2026.

Source: https://millionrounds.com/fund/gilde-healthcare (Millionrounds; every figure on the page links to its filing or article)

Netherlands · [Investor](https://millionrounds.com/investors)

# Gilde Healthcare

Last cheque observed Jun 2026; 56 cheques on record.

Email

Deploying now New fund $280M, Feb 2026 Private equity

Seed Series A Series B Connected-health Wellbeing Healthtech

Follow Gilde Healthcare and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fgilde-healthcare)

Deploying now

**100%** of best year **3** **cheques in 12 months**, 56 on record

Since the last cheque **144** days **00** hrs **00** min **00** sec

Median round **$37M** Rounds led **2 of 56** Sole investor **8 rounds** Exits **10 from the portfolio** Mostly in **United States, 46%**

Pitch Gilde Healthcare

## Gilde Healthcare highlights

- 01 3 cheques in the last 12 months
- 02 Mostly Series B and Series C: 56% of its rounds
- 03 Sole investor in 8 rounds, median $11M
- 04 10 exits from the portfolio

## What they do

> Gilde Healthcare is a specialized healthcare investor managing over €3 billion across three fund strategies: Venture&Growth in healthcare, Private Equity in healthcare and Climate Solutions. From their own website

- **Type:** Private equity (from a list, unverified)
- **Cheque size:** Not stated
- **Stages:** Seed Series A Series B Growth Pre-IPO
- **Sectors:** Connected-health Wellbeing Healthtech
- **Based in:** Utrecht, Netherlands
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **56 appearances**

- **2026** 3 rounds
- **Jun** **[GT Medical Technologies](https://millionrounds.com/company/gt-medical-technologies)** Series E · US · MVM Partners **$100M** With 5 others
- **Apr** **[Endovascular Engineering, Inc. (“E2”)](https://millionrounds.com/company/endovascular-engineering-inc-e2)** Series C · US · Firms' own news pages **$80M** *Led*
- **Feb** **[Big Health](https://millionrounds.com/company/big-health)** US · Gilde Healthcare **$24M** With 11 others
- **2025** 1 round
- **Jan** **[GT Medical Technologies, Inc.](https://millionrounds.com/company/gt-medical-technologies-inc)** Series D · US · MVM Partners **$37M** With 4 others
- **2019** 4 rounds
- **Jul** **[AM-Pharma](https://millionrounds.com/company/am-pharma)** NL · FinSMEs **$130M** With 7 others
- **May** **[Vesper Medical](https://millionrounds.com/company/vesper-medical)** US · Massdevice **$37M** *Led*
- **Feb** **[Calypso Biotech](https://millionrounds.com/company/calypso-biotech)** Series A · NL · FinSMEs **$23M** With 1 other
- **Jan** **[Ablative Solutions](https://millionrounds.com/company/ablative-solutions)** Series D · US · FinSMEs **$77M** With 1 other
- **2018** 1 round
- **May** **[Lava](https://millionrounds.com/company/lava)** NL · FinSMEs **$19M** With 3 others
- **2017** 2 rounds
- **Jul** **[Axonics](https://millionrounds.com/company/axonics)** Series C · US · FinSMEs **$21M** With 2 others
- **Mar** **[Moximed](https://millionrounds.com/company/moximed)** Series C · US · FinSMEs **$50M** With 6 others
- **2015** 3 rounds
- **Sept** **[SANIFIT](https://millionrounds.com/company/sanifit)** Series C · ES **$41M** With 6 others
- **Jun** **[Qinec](https://millionrounds.com/company/qinec)** Series B · GB **$9.2M** With 2 others
- **May** **[Moximed](https://millionrounds.com/company/moximed)** Series B · US **$33M** With 4 others
- **2014** 6 rounds
- **Nov** **[PIERIS Proteolab](https://millionrounds.com/company/pieris-proteolab)** **$8.2M** With 5 others
- **Oct** **[Levicept](https://millionrounds.com/company/levicept)** Series A · GB **$16M** With 2 others
- **Sept** **[AM Pharma](https://millionrounds.com/company/am-pharma)** Series E · NL **$16M** With 5 others
- **Apr** **[Vapotherm](https://millionrounds.com/company/vapotherm)** Series B · US **$24M** With 7 others
- **Mar** **[scPharmaceuticals](https://millionrounds.com/company/scpharmaceuticals)** Series A · US **$16M** With 2 others
- **Jan** **[Viroclinics Biosciences](https://millionrounds.com/company/viroclinics-biosciences)** NL **Undisclosed** Sole investor
- **2013** 1 round
- **Nov** **[Sapiens](https://millionrounds.com/company/sapiens)** Series C · DE **$23M** Sole investor
- **2012** 7 rounds
- **Dec** **[Pharmaline](https://millionrounds.com/company/pharmaline)** NL **Undisclosed** Sole investor
- **Oct** **[Definiens](https://millionrounds.com/company/definiens)** Venture · DE · finsmes.com **$13M** With 1 other
- **Sept** **[BionX™ Medical Technologies, Inc.](https://millionrounds.com/company/bionxtm-medical-technologies-inc)** Series D · US · finsmes.com **$17M** With 3 others
- **Jun** **[Santaris Pharma](https://millionrounds.com/company/santaris-pharma)** Venture · DK · pevc.dowjones.com **$12M** With 5 others
- **May** **[Agendia](https://millionrounds.com/company/agendia)** Growth · NL · bizjournals.com **$65M** With 4 others
- **May** **[Prosonix](https://millionrounds.com/company/prosonix)** Series B · GB · finsmes.com **$27M** With 5 others
- **Jan** **[Moximed](https://millionrounds.com/company/moximed)** Growth · US **$1.8M** With 3 others
- **2011** 5 rounds
- **Nov** **[Inova Labs](https://millionrounds.com/company/inova-labs)** Series B · US · sec.gov **$18M** With 2 others
- **Aug** **[ProFibrix](https://millionrounds.com/company/profibrix)** Series B · NL · onbiovc.com **$11M** With 1 other
- **Jul** **[Prosonix](https://millionrounds.com/company/prosonix)** Series B · GB · growthbusiness.co.uk **$18M** With 4 others
- **Mar** **[Acacia Pharma](https://millionrounds.com/company/acacia-pharma)** Series A · GB · acaciapharma.com **$10M** With 1 other
- **Feb** **[Conatus Pharmaceuticals](https://millionrounds.com/company/conatus-pharmaceuticals)** Series B · US · pharmalive.com **$20M** With 5 others
- **2010** 2 rounds
- **Nov** **[MTM Laboratories](https://millionrounds.com/company/mtm-laboratories)** Series C · US · finsmes.com **$9.7M** With 2 others
- **Oct** **[Stepping Stones Home & Care](https://millionrounds.com/company/stepping-stones-home-and-care)** NL · finsmes.com **Undisclosed** Sole investor
- **2009** 3 rounds
- **Oct** **[MTM Laboratories](https://millionrounds.com/company/mtm-laboratories)** Series C · US · mtmlabs.com **$57M** With 3 others
- **Sept** **[Agendia](https://millionrounds.com/company/agendia)** Series E · NL · fiercebiotech.com **$23M** With 3 others
- **Aug** **[ProFibrix](https://millionrounds.com/company/profibrix)** Series B · NL · dealipedia.com **$11M** Sole investor
- **2008** 2 rounds
- **Jul** **[BG Medicine](https://millionrounds.com/company/bg-medicine)** Series D · US · liquidscenarios.com **$41M** With 3 others
- **Mar** **[PIERIS Proteolab](https://millionrounds.com/company/pieris-proteolab)** Series B · DE · pieris-ag.com **$39M** With 4 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **5 named**

DB **Dirkjan Beugelsdijk** CFO; Director C i Form ADV

ED **Edwin De Graaf** Managing Partner, Director a i Form ADV

JV **Jasper Van Gorp** Managing Partner, Director B i Form ADV

LS **Ludo Suijkerbuijk** Chief Compliance Officer i Form ADV

PV **Pieter Van Der Meer** Managing Partner, Director a i Form ADV

We also hold **34** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## What the register says

From the firm's own filings with the SEC, which it must file accurately by law

**$2.4B** gross assets of its funds Oct 2026

**5+** funds on file numbered funds in its name

**Exempt** reporting adviser venture or small private funds

- **Legal name:** Gilde Healthcare Partners B.v.
- **SEC number:** CRD 163373

## Exits from the portfolio

Companies it backed that were later bought or listed **10 in all**

**[Prosonix](https://millionrounds.com/company/prosonix)** Bought by Circassia **Undisclosed** May 2015

**[Definiens](https://millionrounds.com/company/definiens)** Bought by MedImmune **$150M** Nov 2014

**[Sapiens](https://millionrounds.com/company/sapiens)** Bought by [Medtronic](https://millionrounds.com/fund/medtronic) **$200M** Aug 2014

**[Santaris Pharma](https://millionrounds.com/company/santaris-pharma)** Bought by Roche **$450M** Aug 2014

**[ProFibrix](https://millionrounds.com/company/profibrix)** Bought by The Medicines Company **$240M** Aug 2013

**[Conatus Pharmaceuticals](https://millionrounds.com/company/conatus-pharmaceuticals)** Listed **$69M** Jun 2013

**[MTM Laboratories](https://millionrounds.com/company/mtm-laboratories)** Bought by Roche **Undisclosed** Jul 2011

**[FlowCardia](https://millionrounds.com/company/flowcardia)** Bought by C. R. Bard **Undisclosed** May 2010

**[Ablynx](https://millionrounds.com/company/ablynx)** Listed **Undisclosed** Nov 2007

**[Glycart Biotechnology AG](https://millionrounds.com/company/glycart-biotechnology-ag)** Bought by Roche **Undisclosed** Jul 2005

An exit counts when it came after the firm's first round in the company. From historical deal records.

New fund on file

**$280M**

raised in Feb 2026

From its SEC filing, not a journalist: a firm that has just raised has money to deploy.

## The cheque

Seed Series A Series B

Median round joined **$37M** the round, not its cheque Alone, median **$11M**

Led 2 of 56 rounds **4%**

- **Sole investor:** 8 rounds
- **Last cheque:** Jun 2026
- **Exits:** 10 from the portfolio

Rounds by stage said on their site

- Series B said *12*
- Series C *11*
- Series A said *8*
- Series D *6*
- Venture *4*
- Seed said *-*
- Growth said *-*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [Global Life Science Ventures](https://millionrounds.com/fund/global-life-science-ventures) 8
- [Forbion Capital Partners](https://millionrounds.com/fund/forbion-capital-partners) 5
- [Gimv](https://millionrounds.com/fund/gimv) 5
- [Sofinnova Partners](https://millionrounds.com/fund/sofinnova-partners) 5
- [Morgenthaler Ventures](https://millionrounds.com/fund/morgenthaler) 4
- [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) 4

**Pitching Gilde Healthcare?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Gilde Healthcare. A count of rooms they were both in, not a relationship either has claimed.

[**Global Life Science Ventures** Growth equity **8** rounds together](https://millionrounds.com/fund/global-life-science-ventures)[**Forbion Capital Partners** Private equity **5** rounds together](https://millionrounds.com/fund/forbion-capital-partners)[**Gimv** Private equity **5** rounds together](https://millionrounds.com/fund/gimv)[**Sofinnova Partners** VC firm **5** rounds together](https://millionrounds.com/fund/sofinnova-partners)[**Morgenthaler Ventures** VC firm **4** rounds together](https://millionrounds.com/fund/morgenthaler)[**New Enterprise Associates** VC firm **4** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**Abingworth** VC firm **3** rounds together](https://millionrounds.com/fund/abingworth)[**Index Ventures** VC firm **3** rounds together](https://millionrounds.com/fund/index-ventures)[**Lundbeckfond Ventures** VC firm **3** rounds together](https://millionrounds.com/fund/lundbeckfond-ventures)[**Van Herk Biotech** Growth equity **3** rounds together](https://millionrounds.com/fund/van-herk-biotech)[**Ysios Capital** VC firm **3** rounds together](https://millionrounds.com/fund/ysios-capital)[**Aberdare Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/aberdare-ventures)

## Recently backed

The latest companies Gilde Healthcare put money into.

[**GT Medical Technologies** $100M · Jun 2026](https://millionrounds.com/company/gt-medical-technologies)[**GT Medical Technologies, Inc.** $37M · Jan 2025](https://millionrounds.com/company/gt-medical-technologies-inc)[**AM-Pharma** $130M · Jul 2019](https://millionrounds.com/company/am-pharma)[**Vesper Medical** $37M · May 2019](https://millionrounds.com/company/vesper-medical)[**Ablative Solutions** $77M · Jan 2019](https://millionrounds.com/company/ablative-solutions)[**Lava** $19M · May 2018](https://millionrounds.com/company/lava)

## Quick answers about Gilde Healthcare

### What does Gilde Healthcare invest in?

Gilde Healthcare invests most often at Series B and Series C (56% of the rounds on record), in sectors such as Connected-health, Wellbeing and Healthtech.

### How active is Gilde Healthcare?

56 investments on record, 3 of them in the last 12 months, and it led 2. The most recent was in Jun 2026.

### What has Gilde Healthcare invested in recently?

Its most recent investments on record: GT Medical Technologies (Series E, Jun 2026), Endovascular Engineering, Inc. (“E2”) (Series C, Apr 2026) and Big Health (Undisclosed round, Feb 2026).

### How big are Gilde Healthcare's cheques?

The median round it joins is $37M.

### Does Gilde Healthcare lead rounds?

Sometimes: it led 2 of its 56 investments on record (4%).

### Where does Gilde Healthcare invest?

Most of the companies it backs are in the United States (46%), the Netherlands (28%) and the United Kingdom (13%).

### Is Gilde Healthcare investing now?

Yes: it is actively investing, with 3 investments in the last 12 months.

### Who does Gilde Healthcare invest alongside?

Most often Global Life Science Ventures (8 rounds together), Forbion Capital Partners (5 rounds together) and Gimv (5 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=gilde-healthcare) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=gilde-healthcare)